Q4 results this week: ITC, ONGC, Sun Pharma, Nykaa, Ircon International and IRFC

Q4 results this week: ITC, ONGC, Sun Pharma, Nykaa, Ircon International and IRFC

Various widely tracked companies like ITC, ONGC, IRFC, Ircon International, BHEL, BEL, Sun Pharma, Nykaa, Tata Investment Corporation, Hindalco, Ashok Leyland, and Divi’s lab will be releasing their March quarter report cards this week. Here’s a list: May 20ONGC, Indian Railway Finance Corporation (IRFC), Bharat Electronics (BEL), Oil India, SAIL, Deepak Nitrite, Whirlpool of India, … Read more

Concurrent Gainers: UPL, DLF, Axis Bank among 6 stocks that gained for 5 days in a row

Concurrent Gainers: UPL, DLF, Axis Bank among 6 stocks that gained for 5 days in a row

Upward Trend During the five recent trading sessions ending on April 26, the Sensex benchmark index gained about 1%, closing at 73,730. This upward movement occurred in four out of the last five sessions. Throughout this upward trend, ETMarkets identified 6 stocks within the BSE largecap index that consistently rose in price throughout the last … Read more

Kajaria, Divi’s Laboratories among Prabhudas’ contra buy and sell stocks for 2024 – Contra buys and sells

Kajaria, Divi’s Laboratories among Prabhudas’ contra buy and sell stocks for 2024 – Contra buys and sells

Dr Reddys Laboratories Share Price 5742.95 10:01 AM | 24 Nov 2023 98.30(1.74%) Divis Laboratories Share Price 3751.30 10:01 AM | 24 Nov 2023 62.80(1.70%) Cipla Share Price 1189.25 10:01 AM | 24 Nov 2023 18.60(1.59%) Sun Pharmaceutical Industries Share Price 1208.25 10:01 AM | 24 Nov 2023 9.45(0.79%) NTPC Share Price 254.65 10:01 AM … Read more

Can Divi’s maintain its premium valuation amid headwinds?

Can Divi’s maintain its premium valuation amid headwinds?

Synopsis Indian pharma companies have been struggling to maintain margins because of strong headwinds. Due to increased competition, pharma companies are experiencing price erosion in the market, resulting in sluggish growth. While price erosion is not the only issue at hand, China’s lockdown that caused supply chain disruption, the rise in raw material prices, and … Read more

What makes the latest pharma company to enter Nifty very different from its peers in the index?

What makes the latest pharma company to enter Nifty very different from its peers in the index?

ET Intelligence Group: An 80% gain in the stock of Divi’s Labs during the past five months has catapulted the company into the Nifty-50 Index. The Hyderabad-based pharma company, however, is quite different from peers Sun Pharma, Cipla and Dr Reddy’s Labs, and predecessors Lupin and Aurobindo Pharma in the index. It is the smallest … Read more